MedPath

The Effects of Periodontal Therapy on Glycemic Control in Diabetic Patients

Phase 4
Completed
Conditions
Chronic Periodontitis, Generalized
Interventions
Combination Product: amoxicillin 500mg and metronidazole 400mg
Registration Number
NCT03783845
Lead Sponsor
Taibah University
Brief Summary

Is the non-surgical periodontal therapy can improve glycemic control in type 2 diabetic patients with chronic periodontitis?

Detailed Description

The aim of the present study was to monitor the clinical outcomes and the metabolic response of non-surgical periodontal therapy in patients with chronic periodontitis and uncontrolled type 2 diabetes.

Regarding clinical and metabolic parameters at baseline, no differences were displayed between two groups. However, at 3-months follow-up period the patients within a test group were demonstrated better clinical outcomes than patients in a control group

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
44
Inclusion Criteria

Diagnosis of diabetes type 2 for more than five years Type 2 diabetes with HbA1c level from 7% to 9% at the last medical evaluation Diagnosis with chronic periodontitis

Exclusion Criteria

Pregnancy

  • Alcoholism and smoking
  • Presence of any systemic disorders other than hypertension and diabetes
  • Diabetic major complications

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
test groupamoxicillin 500mg and metronidazole 400mgMetronidazole 400mg,three times daily for two weeks Amoxicillin 500mg,three times daily for two weeks.
Primary Outcome Measures
NameTimeMethod
glycosylated haemoglobin (HbA1c)3 months

Blood was taken from a peripheral vein to monitor HbA1c using high-performance liquid chromatography

Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath